Posted by Michael Wonder on 23 Apr 2020
Drug maker tripled the price of a pill as it pursued coronavirus use
23 April 2020 - This month, Jaguar Health more than tripled the price of its lone FDA approved drug, right after asking the federal government to expand the use of its drug to coronavirus patients.
Jaguar Health drastically raised the price of a drug during the height of the pandemic, but executives argued the move was needed to stave off the company's collapse.
Going into this year, the list price of a 60 pill bottle of Mytesi — an anti-diarrheal medication specifically for people with HIV/AIDS who are on anti-retroviral drugs — was $668.52.
